0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Latex Particle for In-Vitro Diagnostics Market Research Report 2026
Published Date: 2026-04-29
|
Report Code: QYRE-Auto-5Q18171
Home | Market Reports
Global Latex Particle for In Vitro Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Latex Particle for In-Vitro Diagnostics Market Research Report 2026

Code: QYRE-Auto-5Q18171
Report
2026-04-29
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Latex Particle for In-Vitro Diagnostics Market Size

The global Latex Particle for In-Vitro Diagnostics market was valued at US$ 53.54 million in 2025 and is anticipated to reach US$ 77.37 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Latex Particle for In-Vitro Diagnostics Market

Latex Particle for In-Vitro Diagnostics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Latex Particle for In-Vitro Diagnostics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Latex particles, also known as latex microspheres, are small, spherical beads made from synthetic latex polymers (usually polystyrene) that are typically used in a variety of in-vitro diagnostic (IVD) applications. These particles are widely employed due to their high surface area, uniform size, ease of functionalization, and ability to carry various reagents or biomolecules (e.g., antibodies, antigens, nucleic acids) for detecting specific analytes in biological samples.
Latex particles are utilized in diagnostic assays to enhance the detection and quantification of target molecules (such as proteins, DNA, viruses, etc.) in a sample. The interaction between the latex particles and the target analyte produces a measurable signal, often in the form of a color change or fluorescence.
Market Size and Growth
The global in-vitro diagnostics (IVD) market, including latex particles, is expected to grow steadily, driven by an increasing demand for point-of-care testing, disease diagnostics, and home care kits.
Technological Developments
Advances in automation for both latex particle production and the diagnostic processes (such as in high-throughput screening) are driving the adoption of latex-based tests, particularly in clinical labs and high-volume testing environments.
Competitive Landscape
The market for latex particles in diagnostics is highly competitive, with several large multinational companies dominating the market. However, there is also significant competition from specialized companies offering more tailored and niche solutions.
Aging Population
The aging global population is leading to an increase in age-related diseases such as Alzheimer’s, diabetes, and cancer. As the elderly population grows, the demand for effective diagnostic solutions, including those based on latex particles, will continue to rise.
Market Fragmentation
The market for latex particles is fragmented, with different companies focusing on different types of latex products or diagnostic applications. This fragmentation can make it difficult for companies to establish dominant market positions or create large-scale economies.
This report delivers a comprehensive overview of the global Latex Particle for In-Vitro Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Latex Particle for In-Vitro Diagnostics. The Latex Particle for In-Vitro Diagnostics market size, estimates, and forecasts are provided in terms of shipments (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Latex Particle for In-Vitro Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Latex Particle for In-Vitro Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Latex Particle for In-Vitro Diagnostics Market Report

Report Metric Details
Report Name Latex Particle for In-Vitro Diagnostics Market
Accounted market size in 2025 US$ 53.54 million
Forecasted market size in 2032 US$ 77.37 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Plain Latex Particles
  • Carboxy-Modified Latex Particles
  • Other
by Application
  • Latex Immunoturbidimetry
  • Latex Agglutination Test
  • Immunochromatography
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, VDO Biotech, Suzhou NanoMicro, Sunresin New Materials
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Latex Particle for In-Vitro Diagnostics manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Latex Particle for In-Vitro Diagnostics production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Latex Particle for In-Vitro Diagnostics consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Latex Particle for In-Vitro Diagnostics Market growing?

Ans: The Latex Particle for In-Vitro Diagnostics Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Latex Particle for In-Vitro Diagnostics Market size in 2032?

Ans: The Latex Particle for In-Vitro Diagnostics Market size in 2032 will be US$ 77.37 million.

Who are the main players in the Latex Particle for In-Vitro Diagnostics Market report?

Ans: The main players in the Latex Particle for In-Vitro Diagnostics Market are JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, VDO Biotech, Suzhou NanoMicro, Sunresin New Materials

What are the Application segmentation covered in the Latex Particle for In-Vitro Diagnostics Market report?

Ans: The Applications covered in the Latex Particle for In-Vitro Diagnostics Market report are Latex Immunoturbidimetry, Latex Agglutination Test, Immunochromatography, Other

What are the Type segmentation covered in the Latex Particle for In-Vitro Diagnostics Market report?

Ans: The Types covered in the Latex Particle for In-Vitro Diagnostics Market report are Plain Latex Particles, Carboxy-Modified Latex Particles, Other

1 Latex Particle for In-Vitro Diagnostics Market Overview
1.1 Product Definition
1.2 Latex Particle for In-Vitro Diagnostics by Type
1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Plain Latex Particles
1.2.3 Carboxy-Modified Latex Particles
1.2.4 Other
1.3 Latex Particle for In-Vitro Diagnostics by Application
1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Latex Immunoturbidimetry
1.3.3 Latex Agglutination Test
1.3.4 Immunochromatography
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Latex Particle for In-Vitro Diagnostics Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Latex Particle for In-Vitro Diagnostics Production Estimates and Forecasts (2021–2032)
1.4.4 Global Latex Particle for In-Vitro Diagnostics Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Manufacturers (2021–2026)
2.2 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2024 vs 2025
2.4 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Latex Particle for In-Vitro Diagnostics Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offerings and Applications
2.8 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Date of Entry into the Industry
2.9 Latex Particle for In-Vitro Diagnostics Market Competitive Situation and Trends
2.9.1 Latex Particle for In-Vitro Diagnostics Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Latex Particle for In-Vitro Diagnostics Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Latex Particle for In-Vitro Diagnostics Production by Region
3.1 Global Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Region (2021–2032)
3.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Latex Particle for In-Vitro Diagnostics by Region (2027–2032)
3.3 Global Latex Particle for In-Vitro Diagnostics Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Latex Particle for In-Vitro Diagnostics Production Volume by Region (2021–2032)
3.4.1 Global Latex Particle for In-Vitro Diagnostics Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Latex Particle for In-Vitro Diagnostics by Region (2027–2032)
3.5 Global Latex Particle for In-Vitro Diagnostics Market Price Analysis by Region (2021–2026)
3.6 Global Latex Particle for In-Vitro Diagnostics Production, Value, and Year-over-Year Growth
3.6.1 North America Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Latex Particle for In-Vitro Diagnostics Production Value Estimates and Forecasts (2021–2032)
4 Latex Particle for In-Vitro Diagnostics Consumption by Region
4.1 Global Latex Particle for In-Vitro Diagnostics Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Latex Particle for In-Vitro Diagnostics Consumption by Region (2021–2032)
4.2.1 Global Latex Particle for In-Vitro Diagnostics Consumption by Region (2021–2026)
4.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Latex Particle for In-Vitro Diagnostics Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Latex Particle for In-Vitro Diagnostics Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Latex Particle for In-Vitro Diagnostics Production by Type (2021–2032)
5.1.1 Global Latex Particle for In-Vitro Diagnostics Production by Type (2021–2026)
5.1.2 Global Latex Particle for In-Vitro Diagnostics Production by Type (2027–2032)
5.1.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Type (2021–2032)
5.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2021–2032)
5.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2021–2026)
5.2.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Type (2027–2032)
5.2.3 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Type (2021–2032)
5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type (2021–2032)
6 Segment by Application
6.1 Global Latex Particle for In-Vitro Diagnostics Production by Application (2021–2032)
6.1.1 Global Latex Particle for In-Vitro Diagnostics Production by Application (2021–2026)
6.1.2 Global Latex Particle for In-Vitro Diagnostics Production by Application (2027–2032)
6.1.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Application (2021–2032)
6.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2021–2032)
6.2.1 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2021–2026)
6.2.2 Global Latex Particle for In-Vitro Diagnostics Production Value by Application (2027–2032)
6.2.3 Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Application (2021–2032)
6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application (2021–2032)
7 Key Companies Profiled
7.1 JSR Life Sciences
7.1.1 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Company Information
7.1.2 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Portfolio
7.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 JSR Life Sciences Main Business and Markets Served
7.1.5 JSR Life Sciences Recent Developments/Updates
7.2 Merck
7.2.1 Merck Latex Particle for In-Vitro Diagnostics Company Information
7.2.2 Merck Latex Particle for In-Vitro Diagnostics Product Portfolio
7.2.3 Merck Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Merck Main Business and Markets Served
7.2.5 Merck Recent Developments/Updates
7.3 Bangs Laboratories
7.3.1 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Company Information
7.3.2 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Portfolio
7.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Bangs Laboratories Main Business and Markets Served
7.3.5 Bangs Laboratories Recent Developments/Updates
7.4 Thermo Fisher
7.4.1 Thermo Fisher Latex Particle for In-Vitro Diagnostics Company Information
7.4.2 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Portfolio
7.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Thermo Fisher Main Business and Markets Served
7.4.5 Thermo Fisher Recent Developments/Updates
7.5 Agilent
7.5.1 Agilent Latex Particle for In-Vitro Diagnostics Company Information
7.5.2 Agilent Latex Particle for In-Vitro Diagnostics Product Portfolio
7.5.3 Agilent Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Agilent Main Business and Markets Served
7.5.5 Agilent Recent Developments/Updates
7.6 IKERLAT Polymers
7.6.1 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Company Information
7.6.2 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Portfolio
7.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 IKERLAT Polymers Main Business and Markets Served
7.6.5 IKERLAT Polymers Recent Developments/Updates
7.7 Fujikura Kasei
7.7.1 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Company Information
7.7.2 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Portfolio
7.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Fujikura Kasei Main Business and Markets Served
7.7.5 Fujikura Kasei Recent Developments/Updates
7.8 CD Bioparticles
7.8.1 CD Bioparticles Latex Particle for In-Vitro Diagnostics Company Information
7.8.2 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Portfolio
7.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 CD Bioparticles Main Business and Markets Served
7.8.5 CD Bioparticles Recent Developments/Updates
7.9 VDO Biotech
7.9.1 VDO Biotech Latex Particle for In-Vitro Diagnostics Company Information
7.9.2 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Portfolio
7.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 VDO Biotech Main Business and Markets Served
7.9.5 VDO Biotech Recent Developments/Updates
7.10 Suzhou NanoMicro
7.10.1 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Company Information
7.10.2 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Portfolio
7.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Suzhou NanoMicro Main Business and Markets Served
7.10.5 Suzhou NanoMicro Recent Developments/Updates
7.11 Sunresin New Materials
7.11.1 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Company Information
7.11.2 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Portfolio
7.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Sunresin New Materials Main Business and Markets Served
7.11.5 Sunresin New Materials Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis
8.2 Latex Particle for In-Vitro Diagnostics Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Latex Particle for In-Vitro Diagnostics Production Modes and Processes
8.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing
8.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels
8.4.2 Latex Particle for In-Vitro Diagnostics Distributors
8.5 Latex Particle for In-Vitro Diagnostics Customer Analysis
9 Latex Particle for In-Vitro Diagnostics Market Dynamics
9.1 Latex Particle for In-Vitro Diagnostics Industry Trends
9.2 Latex Particle for In-Vitro Diagnostics Market Drivers
9.3 Latex Particle for In-Vitro Diagnostics Market Challenges
9.4 Latex Particle for In-Vitro Diagnostics Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Latex Particle for In-Vitro Diagnostics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Latex Particle for In-Vitro Diagnostics Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Latex Particle for In-Vitro Diagnostics Production Capacity (L) by Manufacturers in 2025
 Table 4. Global Latex Particle for In-Vitro Diagnostics Production by Manufacturers (L), 2021–2026
 Table 5. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Latex Particle for In-Vitro Diagnostics Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Latex Particle for In-Vitro Diagnostics Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Latex Particle for In-Vitro Diagnostics Production Value, 2025
 Table 10. Global Market Latex Particle for In-Vitro Diagnostics Average Price by Manufacturers (US$/L), 2021–2026
 Table 11. Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Date of Entry into the Industry
 Table 14. Global Latex Particle for In-Vitro Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Latex Particle for In-Vitro Diagnostics Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Region (2021–2026)
 Table 19. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Latex Particle for In-Vitro Diagnostics Production Comparison by Region: 2021 vs 2025 vs 2032 (L)
 Table 22. Global Latex Particle for In-Vitro Diagnostics Production (L) by Region (2021–2026)
 Table 23. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2021–2026)
 Table 24. Global Latex Particle for In-Vitro Diagnostics Production (L) Forecast by Region (2027–2032)
 Table 25. Global Latex Particle for In-Vitro Diagnostics Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Latex Particle for In-Vitro Diagnostics Market Average Price (US$/L) by Region (2021–2026)
 Table 27. Global Latex Particle for In-Vitro Diagnostics Market Average Price (US$/L) by Region (2027–2032)
 Table 28. Global Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (L)
 Table 29. Global Latex Particle for In-Vitro Diagnostics Consumption by Region (L), 2021–2026
 Table 30. Global Latex Particle for In-Vitro Diagnostics Consumption Market Share by Region (2021–2026)
 Table 31. Global Latex Particle for In-Vitro Diagnostics Forecasted Consumption by Region (L), 2027–2032
 Table 32. Global Latex Particle for In-Vitro Diagnostics Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (L)
 Table 34. North America Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2021–2026
 Table 35. North America Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2027–2032
 Table 36. Europe Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (L)
 Table 37. Europe Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2021–2026
 Table 38. Europe Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2027–2032
 Table 39. Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (L)
 Table 40. Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption by Region (L), 2021–2026
 Table 41. Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption by Region (L), 2027–2032
 Table 42. Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (L)
 Table 43. Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2021–2026
 Table 44. Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption by Country (L), 2027–2032
 Table 45. Global Latex Particle for In-Vitro Diagnostics Production (L) by Type (2021–2026)
 Table 46. Global Latex Particle for In-Vitro Diagnostics Production (L) by Type (2027–2032)
 Table 47. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Type (2021–2026)
 Table 48. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Type (2027–2032)
 Table 49. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Type (2021–2026)
 Table 52. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Type (2027–2032)
 Table 53. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Type (2021–2026)
 Table 54. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Type (2027–2032)
 Table 55. Global Latex Particle for In-Vitro Diagnostics Production (L) by Application (2021–2026)
 Table 56. Global Latex Particle for In-Vitro Diagnostics Production (L) by Application (2027–2032)
 Table 57. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Application (2021–2026)
 Table 58. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Application (2027–2032)
 Table 59. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Application (2021–2026)
 Table 62. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Application (2027–2032)
 Table 63. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Application (2021–2026)
 Table 64. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Application (2027–2032)
 Table 65. JSR Life Sciences Latex Particle for In-Vitro Diagnostics Company Information
 Table 66. JSR Life Sciences Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 67. JSR Life Sciences Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 68. JSR Life Sciences Main Business and Markets Served
 Table 69. JSR Life Sciences Recent Developments/Updates
 Table 70. Merck Latex Particle for In-Vitro Diagnostics Company Information
 Table 71. Merck Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 72. Merck Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 73. Merck Main Business and Markets Served
 Table 74. Merck Recent Developments/Updates
 Table 75. Bangs Laboratories Latex Particle for In-Vitro Diagnostics Company Information
 Table 76. Bangs Laboratories Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 77. Bangs Laboratories Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 78. Bangs Laboratories Main Business and Markets Served
 Table 79. Bangs Laboratories Recent Developments/Updates
 Table 80. Thermo Fisher Latex Particle for In-Vitro Diagnostics Company Information
 Table 81. Thermo Fisher Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 82. Thermo Fisher Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 83. Thermo Fisher Main Business and Markets Served
 Table 84. Thermo Fisher Recent Developments/Updates
 Table 85. Agilent Latex Particle for In-Vitro Diagnostics Company Information
 Table 86. Agilent Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 87. Agilent Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 88. Agilent Main Business and Markets Served
 Table 89. Agilent Recent Developments/Updates
 Table 90. IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Company Information
 Table 91. IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 92. IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 93. IKERLAT Polymers Main Business and Markets Served
 Table 94. IKERLAT Polymers Recent Developments/Updates
 Table 95. Fujikura Kasei Latex Particle for In-Vitro Diagnostics Company Information
 Table 96. Fujikura Kasei Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 97. Fujikura Kasei Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 98. Fujikura Kasei Main Business and Markets Served
 Table 99. Fujikura Kasei Recent Developments/Updates
 Table 100. CD Bioparticles Latex Particle for In-Vitro Diagnostics Company Information
 Table 101. CD Bioparticles Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 102. CD Bioparticles Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 103. CD Bioparticles Main Business and Markets Served
 Table 104. CD Bioparticles Recent Developments/Updates
 Table 105. VDO Biotech Latex Particle for In-Vitro Diagnostics Company Information
 Table 106. VDO Biotech Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 107. VDO Biotech Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 108. VDO Biotech Main Business and Markets Served
 Table 109. VDO Biotech Recent Developments/Updates
 Table 110. Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Company Information
 Table 111. Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 112. Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 113. Suzhou NanoMicro Main Business and Markets Served
 Table 114. Suzhou NanoMicro Recent Developments/Updates
 Table 115. Sunresin New Materials Latex Particle for In-Vitro Diagnostics Company Information
 Table 116. Sunresin New Materials Latex Particle for In-Vitro Diagnostics Specification and Application
 Table 117. Sunresin New Materials Latex Particle for In-Vitro Diagnostics Production (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021–2026)
 Table 118. Sunresin New Materials Main Business and Markets Served
 Table 119. Sunresin New Materials Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Latex Particle for In-Vitro Diagnostics Distributors List
 Table 123. Latex Particle for In-Vitro Diagnostics Customers List
 Table 124. Latex Particle for In-Vitro Diagnostics Market Trends
 Table 125. Latex Particle for In-Vitro Diagnostics Market Drivers
 Table 126. Latex Particle for In-Vitro Diagnostics Market Challenges
 Table 127. Latex Particle for In-Vitro Diagnostics Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Latex Particle for In-Vitro Diagnostics
 Figure 2. Global Latex Particle for In-Vitro Diagnostics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Latex Particle for In-Vitro Diagnostics Market Share by Type: 2025 vs 2032
 Figure 4. Plain Latex Particles Product Picture
 Figure 5. Carboxy-Modified Latex Particles Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Latex Particle for In-Vitro Diagnostics Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Latex Particle for In-Vitro Diagnostics Market Share by Application: 2025 vs 2032
 Figure 9. Latex Immunoturbidimetry
 Figure 10. Latex Agglutination Test
 Figure 11. Immunochromatography
 Figure 12. Other
 Figure 13. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Latex Particle for In-Vitro Diagnostics Production Value (US$ Million), 2021–2032
 Figure 15. Global Latex Particle for In-Vitro Diagnostics Production Capacity (L), 2021–2032
 Figure 16. Global Latex Particle for In-Vitro Diagnostics Production (L), 2021–2032
 Figure 17. Global Latex Particle for In-Vitro Diagnostics Average Price (US$/L), 2021–2032
 Figure 18. Latex Particle for In-Vitro Diagnostics Report Years Considered
 Figure 19. Latex Particle for In-Vitro Diagnostics Production Share by Manufacturers in 2025
 Figure 20. Global Latex Particle for In-Vitro Diagnostics Production Value Share by Manufacturers (2025)
 Figure 21. Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Top 5 and Top 10 Global Players: Market Share by Latex Particle for In-Vitro Diagnostics Revenue in 2025
 Figure 23. Global Latex Particle for In-Vitro Diagnostics Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 24. Global Latex Particle for In-Vitro Diagnostics Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 25. Global Latex Particle for In-Vitro Diagnostics Production Comparison by Region: 2021 vs 2025 vs 2032 (L)
 Figure 26. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 27. North America Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Europe Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 29. China Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 30. Japan Latex Particle for In-Vitro Diagnostics Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 31. Global Latex Particle for In-Vitro Diagnostics Consumption by Region: 2021 vs 2025 vs 2032 (L)
 Figure 32. Global Latex Particle for In-Vitro Diagnostics Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 33. North America Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 34. North America Latex Particle for In-Vitro Diagnostics Consumption Market Share by Country (2021–2032)
 Figure 35. U.S. Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 36. Canada Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 37. Europe Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 38. Europe Latex Particle for In-Vitro Diagnostics Consumption Market Share by Country (2021–2032)
 Figure 39. Germany Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 40. France Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 41. U.K. Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 42. Italy Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 43. Russia Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 44. Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 45. Asia Pacific Latex Particle for In-Vitro Diagnostics Consumption Market Share by Region (2021–2032)
 Figure 46. China Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 47. Japan Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 48. South Korea Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 49. China Taiwan Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 50. Southeast Asia Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 51. India Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 52. Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 53. Latin America, Middle East & Africa Latex Particle for In-Vitro Diagnostics Consumption Market Share by Country (2021–2032)
 Figure 54. Mexico Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 55. Brazil Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 56. Turkey Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 57. GCC Countries Latex Particle for In-Vitro Diagnostics Consumption and Growth Rate (L), 2021–2032
 Figure 58. Global Production Market Share of Latex Particle for In-Vitro Diagnostics by Type (2021–2032)
 Figure 59. Global Production Value Market Share of Latex Particle for In-Vitro Diagnostics by Type (2021–2032)
 Figure 60. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Type (2021–2032)
 Figure 61. Global Production Market Share of Latex Particle for In-Vitro Diagnostics by Application (2021–2032)
 Figure 62. Global Production Value Market Share of Latex Particle for In-Vitro Diagnostics by Application (2021–2032)
 Figure 63. Global Latex Particle for In-Vitro Diagnostics Price (US$/L) by Application (2021–2032)
 Figure 64. Latex Particle for In-Vitro Diagnostics Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc